STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.Navin Pinto, Julie R. Park, Kristy Seidel et al.|Journal of Clinical Oncology|2022Cited by 27
STRIvE-01: Phase I study of EGFR806 CAR T-cell immunotherapy for recurrent/refractory solid tumors in children and young adults.Catherine M. Albert, Julie R. Park, Navin Pinto et al.|Journal of Clinical Oncology|2022Cited by 17
Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity.Rebecca Gardner, Michael C. Jensen, Colleen Annesley et al.|Journal of Clinical Oncology|2020Cited by 13
Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML.Todd M. Cooper, Rebecca Gardner, Vicky Wu et al.|Journal of Clinical Oncology|2022Cited by 8
Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment.Navin Pinto, Julie R. Park, Catherine M. Albert et al.|Journal of Clinical Oncology|2023Cited by 2